«Previous Article|Table of Contents|Next Article»

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:

2025 02

Page:

269-274

Research Field:

Publishing date:

Info

Title:

Analysis of clinicopathological features and prognostic factors in 5 cases of primary ovarian goiter carcinoid

Author(s):

WEI Xin¹; ZHANG Yanrui¹; LU Xiangyu¹; LIU Limin²

1.Department of Pathology;2.Department of Gynecology,Shenzhen Maternal and Child Healthcare Hospital,Guangdong Shenzhen 518028,China.

Keywords:

ovary; carcinoid; goiter

PACS:

R736

DOI:

10.3969/j.issn.1672-4992.2025.02.015

Abstract:

Objective:To dicuss the clinicopathological features and prognostic risk factors of primary ovarian goiter carcinoid.Methods:The clinical data,microscopic morphology,immunohistochemical phenotype and survival status of 5 patients with primary ovarian carcinoid treated in Shenzhen Maternal and Child Health Hospital from January 2010 to September 2023 were retrospectively analyzed,and the pathological characteristics,clinical treatment methods,postoperative survival and risk factors affecting prognosis of primary ovarian carcinoid were summarized and analyzed.Results:Five female patients,all with unilateral ovarian goiter carcinoid,did not receive adjuvant treatment after surgery,3 cases were followed up for more than 11 years, the other 2 cases were followed up for 9 months and 4 months, respectively,and no tumor recurrence or metastasis was found.Conclusion:Stage I ovarian carcinoid has a good prognosis,and the scope of surgery should be evaluated according to the patient's age and fertility requirements.Close monitoring and regular follow-up should be conducted after surgery,and adjuvant therapy is not recommended.For patients with metastasis or risk factors that may affect prognosis,clinicians need to make a comprehensive analysis and formulate an appropriate treatment plan,to minimize the harm to patients without shortening the survival time.

References:

[1]VORA M,LACOUR R,BLACK D,et al.Neuroendocrine tumors in the ovary:histogenesis,pathologic differentiation,and clinical presentation£ÛJ£Ý.Archives of Gynecology and Obstetrics,2016,293(3):659-665.
[2]OLIVA E,YOUNG R,SCULLY R,et al.Ovarian mucinous carcinoids including some with a carcinomatous component a report of 17 cases£ÛJ£Ý.The American Journal of Surgical Pathology,2001,25(5):557-568.
[3]ENGOHAN-ALOGHE C,BUXANT F,NO¦ML JC.Primary ovarian carcinoid tumor with luteinized stromal cells£ÛJ£Ý.Arch Gynecol Obstet,2009,280(1):119-121.
[4]GEORGESCU TA,BOHILTEA RE,MUNTEANU O,et al.Emerging therapeutic concepts and latest diagnostic advancements regarding neuroendocrine tumors of the gynecologic tract£ÛJ£Ý.Medicina,2021,57£¨12£©£º1-16.
[5]KURABAYASHI T,MINAMIKAWA T,NISHIJIMA S,et al.Primarystrumal carcinoid tumor of the ovary with multiple bone and breast metastases£ÛJ£Ý.Obstet Gynaecol Res,2010,36(3):567-571.
[6]KIM HS,YOON G,JANG HI,et al.Primary ovarian carcinoid tumor showing unusual histology and nuclear accumulation of ¦Â-catenin£ÛJ£Ý.Int J Clin Exp Pathol,2015,8(5):5749-5752.
[7]OPALINSKA M,SOWA-STASZCZAK A,OLEARSKA H,et al.Clinical approach to neuroendocrine neoplasm associated with ovarian teratoma£Û£Ê£Ý.Frontiers in Endocrinology,2021,12:1-8.
[8]HAYASHI T,HABA R,KUSHIDA Y,et al.Cytopathologic characteristics of the primary strumal carcinoid tumor of the ovary:A case report with emphasis on differential diagnostic considerations£ÛJ£Ý.Diagnostic Cytopathology,2011,41(9):812-816.
[9]KAIHO-SAKUMA M,TOYOSHIMA M£¬WATANABE M,et al.Aggressive neuroendocrine tumor of the ovary with multiple metastases treated with everolimus:A case report£ÛJ£Ý.Gynecologic Oncology Reports,2018,23:20-23.
[10]WHO Classification of Tumours Editorial Board.WHO classification of female genital tumours£ÛM£Ý.5th.Lyon,France:IARC Press,2020:452-459.
[11]WHO Classification of Tumours Editorial Board.WHO classification of thoracic tumours£ÛM£Ý.5th.Lyon,France:IARC Press,2021:127-138.
[12]WHO Classification of Tumours Editorial Board.WHO classification of digestive system tumours£ÛM£Ý.5th.Lyon,France:IARC Press,2019:16-19.
[13]ZHANG X,JONES A,JENKINS SM,et al.Ki67 proliferative index in carcinoid tumors involving ovary£ÛJ£Ý.Endocrine Pathology,2018,29(1):43-48.
[14]KONG S,SUN J,SUI X,et al.Clinical characteristics and survival outcomes in patients with primary ovarian carcinoid:A historical cohort study£ÛJ£Ý.Acta Obstetricia et Gynecologica Scandinavica,2023,102£¨7£©:935-941.
[15]LI S,WANG X,SUI X,et al.Clinical characteristics and survival outcomes in patients with ovarian strumal carcinoid£ÛJ£Ý.BMC Cancer,2022,22(1):1-9.
[16]XIA ZY,CHEN PF,CHENL S,et al.A case of primary ovarian carcinoid and the review of the literature£ÛJ£Ý.Cancer Advances,2023,3:1-4.
[17]TURLA A,ZAMPARINI M,MILIONE M,et al.Ovarian strumal carcinoid:Case report,systematic literature review and pooled analysis£ÛJ£Ý.Frontiers in Endocrinology,2022,13:1-10.
[18]BORGHESE M,RAZZORE P,FERRERO A,et al.Metastatic bilateral strumal carcinoid:A case report and review of the literature£ÛJ£Ý.Anticancer Research,2019,39£¨9£©:5053-5056.
[19]TSIKOURAS P,DIMITRAKI M,BOTHOU A,et al.Primary ovarian carcinoid tumors:our experience and review of the literature£ÛJ£Ý.European Journal of Gynaecological Oncology,2019,40(3):361-367.
[20]HUANG W,BAO Y,LUO X,et al.Neuroendocrine neoplasms of the ovary:an analysis of clinicopathological characteristics and prognosis with a focus on histological grading£ÛJ£Ý.Endocrine,2022,77(1):188-198.
[21]SOGA J,OSAKA M,YAKUWA Y.Carcinoids of the ovary:an analysis of 329 reported cases£ÛJ£Ý.J Exp Clin Cancer Res,2000,19(3):271-280.
[22]AMANO Y,MANDAI M,BABA T,et al.Recurrence of a carcinoid tumor of the ovary 13 years after the primary surgery:A case report£ÛJ£Ý.Oncology Lettera,2013,6(5):1241-1244.
[23]LOU L,ZHOU L,WANG W,et al.Atypical ovarian carcinoid tumor with widespread skeletal metastases:a casereport of multiple endocrine neoplasia type1 in a young woman£ÛJ£Ý.BMC Cancer,2019,19(1):1-7.
[24]ROMPUY AV,VANDERSTICHELE A,VERGOTE I,et al.Diffusely metastasized adenocarcinoma arising in a mucinous carcinoid of the ovary:A case report£ÛJ£Ý.International Journal of Gynecological Pathology,2018,37(3):290-295.
[25]BUIS CC,VAN DOORN HC,DINJENS WN,et al.Mucinous carcinoid of the ovary:report of a case with metastasis in the contralateral ovary after ten years£ÛJ£Ý.Rare Tumors,2010,2(3):106-107.
[26]HSU WW,MAO TL,CHEN CH.Primary ovarian mucinous carcinoid tumor:A case report and review of literature£ÛJ£Ý.Taiwanese Journal of Obstetrics and Gynecology,2019,58(4):570-573.
[27]NASIOUDIS D,FREY MK,CHAPMAN-DAVIS E,et al.Primary malignant ovarian carcinoid management and outcomes£ÛJ£Ý.Gynecologic Oncology,2020,157(1):101-105.

Memo

Memo:

¹ã¶«Ê¡ÉîÛÚÊпƴ´Î¯»ù´¡Ñо¿ÏîÄ¿(±àºÅ£ºJCYJ20220530155006014)

Common functions

Last Update: 1900-01-01